CZ295675B6 - Způsob přípravy derivátu dihydro-2,3-benzodiazepinu a meziprodukty tohoto způsobu přípravy - Google Patents

Způsob přípravy derivátu dihydro-2,3-benzodiazepinu a meziprodukty tohoto způsobu přípravy Download PDF

Info

Publication number
CZ295675B6
CZ295675B6 CZ19952219A CZ221995A CZ295675B6 CZ 295675 B6 CZ295675 B6 CZ 295675B6 CZ 19952219 A CZ19952219 A CZ 19952219A CZ 221995 A CZ221995 A CZ 221995A CZ 295675 B6 CZ295675 B6 CZ 295675B6
Authority
CZ
Czechia
Prior art keywords
group
compound
formula
aryl
nitrophenyl
Prior art date
Application number
CZ19952219A
Other languages
Czech (cs)
English (en)
Other versions
CZ221995A3 (en
Inventor
Benjamin Alan Anderson
Marvin Martin Hansen
Jeffrey Thomas Vicenzi
David Lee Varie
Milton Joseph Junior Zmijewski
Original Assignee
Eli Lilly And Company Lilly Corporate Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/413,036 external-priority patent/US5665878A/en
Application filed by Eli Lilly And Company Lilly Corporate Center filed Critical Eli Lilly And Company Lilly Corporate Center
Publication of CZ221995A3 publication Critical patent/CZ221995A3/cs
Publication of CZ295675B6 publication Critical patent/CZ295675B6/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/056Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CZ19952219A 1994-08-31 1995-08-30 Způsob přípravy derivátu dihydro-2,3-benzodiazepinu a meziprodukty tohoto způsobu přípravy CZ295675B6 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29864594A 1994-08-31 1994-08-31
US08/413,036 US5665878A (en) 1994-08-31 1995-03-28 Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives

Publications (2)

Publication Number Publication Date
CZ221995A3 CZ221995A3 (en) 1996-03-13
CZ295675B6 true CZ295675B6 (cs) 2005-09-14

Family

ID=26970799

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ19952219A CZ295675B6 (cs) 1994-08-31 1995-08-30 Způsob přípravy derivátu dihydro-2,3-benzodiazepinu a meziprodukty tohoto způsobu přípravy

Country Status (21)

Country Link
US (3) US5919954A (en, 2012)
EP (1) EP0699677B1 (en, 2012)
JP (1) JP3481019B2 (en, 2012)
KR (1) KR100399518B1 (en, 2012)
CN (1) CN1086705C (en, 2012)
AT (1) ATE231867T1 (en, 2012)
AU (1) AU702658B2 (en, 2012)
BR (1) BR9503845A (en, 2012)
CA (1) CA2157234C (en, 2012)
CZ (1) CZ295675B6 (en, 2012)
DE (1) DE69529499T2 (en, 2012)
DK (1) DK0699677T3 (en, 2012)
ES (1) ES2189819T3 (en, 2012)
FI (1) FI113269B (en, 2012)
HU (1) HU223776B1 (en, 2012)
IL (1) IL115100A (en, 2012)
IN (1) IN190402B (en, 2012)
NO (1) NO312838B1 (en, 2012)
PL (3) PL190640B1 (en, 2012)
RU (1) RU2151149C1 (en, 2012)
TR (1) TR199501071A2 (en, 2012)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69820081D1 (de) * 1997-08-12 2004-01-08 Egyt Gyogyszervegyeszeti Gyar 1-3 dioxolo/4.5-h//2,3-benzodiazepin derivate als ampa/kainate-rezeptor-hemmer
UA67749C2 (uk) * 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування
WO1999023242A1 (en) * 1997-11-04 1999-05-14 Eli Lilly And Company Ketoreductase gene and protein from yeast
US20030219456A1 (en) * 2002-05-21 2003-11-27 Taing Ok Method of utilization of zygosaccharomyces rouxii
US6858605B2 (en) 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives
ES2322069T3 (es) * 2005-12-05 2009-06-16 Deutsche Post Ag Procedimiento para la clasificacion de envios postales y dispositivo con una estructura de datos para un plan de clasificacion.
AU2006334172A1 (en) * 2005-12-30 2007-07-12 Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis
KR100841592B1 (ko) 2007-04-16 2008-06-26 한양대학교 산학협력단 벤조디옥솔 유도체와 이의 제조방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3748342A (en) * 1971-05-06 1973-07-24 Sandoz Ag Intermediates for preparing quinazolinones
US3794642A (en) * 1973-01-15 1974-02-26 Lilly Co Eli Oxidation of substituted methanes to the corresponding substituted methanols
DE2816475A1 (de) * 1978-04-15 1979-10-25 Bayer Ag Isochroman-derivate, verfahren zu ihrer herstellung und ihre verwendung als synergisten in insektiziden und akariziden mitteln
US4358041A (en) 1980-06-12 1982-11-09 Olin Corporation Powder-actuated tool with power adjustment and angle-fire control
HU191702B (en) * 1984-06-27 1987-03-30 Gyogyszerkutato Intezet New process for preparing 1-aryl-5 h-2,3-benzodiazepines
HU191698B (en) * 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines
HU198494B (en) 1986-08-15 1989-10-30 Gyogyszerkutato Intezet Process for producing new 3,4-dihydro-5h-2,3-benzodiazepine derivative and acid addition salts thereof, as well as pharmaceutical compositions comprising same
EP0357787B1 (en) * 1988-02-12 1996-05-08 Daicel Chemical Industries, Ltd. Process for preparing optically active 2-hydroxy acid derivatives
JP2679145B2 (ja) * 1988-09-02 1997-11-19 ダイセル化学工業株式会社 オキシケトンの製造法
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
HU206719B (en) 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
JP3061422B2 (ja) * 1990-12-27 2000-07-10 ダイセル化学工業株式会社 光学活性(s)−2−クロロ−1−フェニルプロパノールの製造法
JPH04271789A (ja) * 1991-01-10 1992-09-28 Takeda Chem Ind Ltd D−パントラクトンの製造方法
HU219777B (hu) * 1993-07-02 2001-07-30 Gyógyszerkutató Intézet Kft. Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására

Also Published As

Publication number Publication date
NO312838B1 (no) 2002-07-08
HU223776B1 (hu) 2005-01-28
NO953396D0 (no) 1995-08-30
EP0699677B1 (en) 2003-01-29
DK0699677T3 (da) 2003-04-22
PL188796B1 (pl) 2005-04-29
CZ221995A3 (en) 1996-03-13
FI954064A0 (fi) 1995-08-30
CA2157234A1 (en) 1996-03-01
ES2189819T3 (es) 2003-07-16
PL190318B1 (pl) 2005-11-30
PL190640B1 (pl) 2005-12-30
CN1086705C (zh) 2002-06-26
US5986114A (en) 1999-11-16
IL115100A (en) 2000-07-26
DE69529499D1 (de) 2003-03-06
CN1123282A (zh) 1996-05-29
KR100399518B1 (ko) 2004-04-30
NO953396L (no) 1996-03-01
RU2151149C1 (ru) 2000-06-20
TR199501071A2 (tr) 1996-06-21
IN190402B (en, 2012) 2003-07-26
IL115100A0 (en) 1995-12-08
FI954064L (fi) 1996-03-01
HUT72644A (en) 1996-05-28
AU702658B2 (en) 1999-02-25
KR960007595A (ko) 1996-03-22
US5919954A (en) 1999-07-06
FI113269B (fi) 2004-03-31
CA2157234C (en) 2005-05-03
PL310226A1 (en) 1996-03-04
JPH0881468A (ja) 1996-03-26
US6160133A (en) 2000-12-12
BR9503845A (pt) 1996-04-16
EP0699677A1 (en) 1996-03-06
HU9502545D0 (en) 1995-10-30
JP3481019B2 (ja) 2003-12-22
DE69529499T2 (de) 2003-12-04
ATE231867T1 (de) 2003-02-15
HK1013818A1 (en) 1999-09-10
AU3035595A (en) 1996-03-14

Similar Documents

Publication Publication Date Title
CZ295675B6 (cs) Způsob přípravy derivátu dihydro-2,3-benzodiazepinu a meziprodukty tohoto způsobu přípravy
US5665878A (en) Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives
NZ292417A (en) 7h-1,3-dioxolo[4,5-h] [2,3]-benzodiazepine derivatives and medicaments
CZ288679B6 (cs) Krystalická forma (R)-7-acetyl-5-(4-aminofenyl)-8,9-dihydro-8-methyl-7H-1,3-dioxolo-[4,5-h][2,3]benzodiazepinu, způsob její přípravy a farmaceutický prostředek, který ji obsahuje
AU696243B2 (en) Physical form of a dihydro-2,3-benzodiazepine derivatives
HK1013818B (en) Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives
HK1013819B (en) Physical form of dihidro-2,3-benzodiazepine derivative
HK1013820B (en) Crystalline form of dihydro-2,3-benzodiazepine derivative

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20110830